Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia
Clinical trials sponsored by Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, explained in plain language.
-
New study follows CAR-T cells in blood cancer patients
Disease control Recruiting nowThis study looks at how well CAR-T cell therapy works for people with certain blood cancers like lymphoma and leukemia. Researchers will track the CAR-T cells in the body after infusion and measure how the disease responds. The study includes 45 patients who have not improved aft…
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated May 26, 2026 12:13 UTC
-
Immunotherapy may stall rare adrenal cancer progression
Disease control Recruiting nowThis study tests whether the immunotherapy drug cemiplimab can delay or prevent cancer growth in people with advanced adrenocortical cancer whose disease was controlled by initial chemotherapy. About 31 adults whose cancer did not worsen after 4-6 cycles of first-line treatment w…
Phase: PHASE2 • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
Eye movement therapy may calm emotional storms in borderline personality disorder
Symptom relief Recruiting nowThis study is testing whether a therapy called EMDR, which is known for treating PTSD, can also help people with borderline personality disorder (BPD). The goal is to see if EMDR can improve emotional control and reduce core BPD symptoms. The study will involve 56 adults with BPD…
Phase: NA • Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Symptom relief
Last updated May 26, 2026 12:03 UTC
-
Eye transplant breakthrough: new check could save sight
Knowledge-focused Recruiting nowThis study involves 135 adults who need a corneal transplant. Researchers want to see if a simple check by the surgeon before surgery can predict how well the donated tissue will work. The goal is to reduce the chance of transplant failure and help more people keep their sight.
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Knowledge-focused
Last updated May 26, 2026 12:09 UTC
-
Scientists hunt for hidden leukemia genes in families
Knowledge-focused Recruiting nowThis study aims to find inherited gene changes that increase the risk of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Researchers will use advanced DNA sequencing to test affected and healthy family members. The goal is to discover new or known mutations that…
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
AI steps in to validate promising leukemia treatment without a traditional trial
Knowledge-focused Recruiting nowThis study uses artificial intelligence and real-world patient data to compare a new drug combination (venetoclax plus decitabine) against standard chemotherapy for elderly patients (ages 60-75) with acute myeloid leukemia (AML). Researchers will analyze records from nearly 2,000…
Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia • Aim: Knowledge-focused
Last updated May 06, 2026 16:14 UTC